Skip to main content
OpenTrials

Clinical trial condition

Infections, Meningococcal

Explore clinical trials studying Infections, Meningococcal. Study availability and eligibility vary by location and protocol.

65 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Infections, Meningococcal trial results

Completed

Co-Administration of Meningococcal Vaccine GSK134612 With Infanrix Hexa™ Versus Individual Administration of Each Vaccine

NCT00508261

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • GSK Investigational Site Eferding, Austria
  • GSK Investigational Site Neufeld/Leitha, Austria
  • GSK Investigational Site Salzburg, Austria
  • GSK Investigational Site Villach, Austria
View all 89 locations
View Trial Details
Completed

Combined Study - Phase 3b MenB Long Term Persistence in Adolescents

NCT02446743

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Diseases, +8 more
Locations
  • GSK Investigational Site Sherwood, Queensland, Australia
  • GSK Investigational Site North Adelaide, South Australia, Australia
  • GSK Investigational Site Carlton, Victoria, Australia
  • GSK Investigational Site Subiaco, Western Australia, Australia
View Trial Details
Completed

Immuno,Safety of GSK Vaccine 134612 Given at Age of 12-15 Months 15-18 Months Post-priming With GSK Vaccine 792014

NCT00614614

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Dothan, Alabama, United States
  • GSK Investigational Site Benton, Arkansas, United States
View all 56 locations
View Trial Details
Completed

Safety and Immunogenicity of GlaxoSmithKline Biologicals Meningococcal Group B Vaccine When Administered Concomitantly With GlaxoSmithKline Biologicals MenACWY Conjugate Vaccine to Healthy Infants

NCT02106390

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Diseases, +8 more
Locations
  • GSK Investigational Site Buenos Aires, Argentina
  • GSK Investigational Site Buenos Aires, Argentina
  • GSK Investigational Site Córdoba, Argentina
  • GSK Investigational Site Mexico City, Mexico
View Trial Details

Related conditions